Impact of sodium-glucose cotransporter-2 (SLGT2) inhibitors treatment initiation on the reduction of atrial and ventricular arrhythmias in patients with implanted cardiac devices.
Event:
ESC Congress 2023
Topic:
Antiarrhythmic Drug Treatment
Session:
Update on EP studies, anti-arrhythmic drugs, and ablation techniques